BioNTech SE (BNTX) EBITDA Margin (2018 - 2025)
BioNTech SE's (BNTX) quarterly EBITDA Margin came in at 35.57% in Q4 2025, down 3558.0% year-on-year from 1.03% in Q4 2024, and down 1052.1% quarter-over-quarter from 3.09% in Q3 2025.
BioNTech SE (BNTX) EBITDA Margin (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed EBITDA Margin across 8 years of filings, most recently posting 35.57% for Q4 2025.
- EBITDA Margin for Q4 2025 came in at 35.57%, down 3558.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 54.43% (down 5440.0% YoY), and the FY2025 annual result was 1870.71%, down 182293.0% from the prior year.
- EBITDA Margin came in at 35.57% for Q4 2025 at BioNTech SE, down from 3.09% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 84.95% in Q4 2021 to a low of 6424.36% in Q2 2025.
- The 5-year median for EBITDA Margin is 26.28% (2023), against an average of 731.68%.
- Peak annual rise in EBITDA Margin reached 321089 bps in 2025, while the deepest fall reached 567362 bps in 2025.
- BioNTech SE's EBITDA Margin stood at 84.95% in 2021, then declined by 9 bps to 76.97% in 2022, then plunged by 54 bps to 35.58% in 2023, then sank by 100 bps to 0.0% in 2024, then sank by 790105 bps to 35.57% in 2025.
- The last three EBITDA Margin figures came in at 35.57% (Q4 2025), 3.09% (Q3 2025), and 6424.36% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | -35.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35.57% |
| Sep 30, 2025 | -3.09% |
| Jun 30, 2025 | -6,424.36% |
| Mar 31, 2025 | -2,302.16% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 15.01% |
| Jun 30, 2024 | -750.74% |
| Mar 31, 2024 | -5,513.04% |
| Dec 31, 2023 | 35.58% |
| Sep 30, 2023 | 16.98% |
| Jun 30, 2023 | -335.90% |
| Mar 31, 2023 | 51.25% |
| Dec 31, 2022 | 76.97% |
| Sep 30, 2022 | 68.98% |
| Jun 30, 2022 | 69.13% |
| Mar 31, 2022 | 74.56% |
| Dec 31, 2021 | 84.95% |
| Sep 30, 2021 | 77.60% |
| Jun 30, 2021 | 79.09% |
| Mar 31, 2021 | 81.15% |